Jupiter Neurosciences is selling 307,692 shares of common stock at $6.50 apiece through D. Boral Capital, which earns a 7.0% Placement fee. Buyers face immediate dilution of $3.73 per share, and proceeds fund working Capital and general corporate purposes.

Key Highlights

  • Jupiter Neurosciences is selling 307,692 shares of common stock at $6.50 per share through placement agent D. Boral Capital LLC on a best-efforts basis.
  • D. Boral Capital LLC will collect a cash fee equal to 7.0% of gross proceeds, plus reimbursed legal expenses capped at $75,000.
  • The offering follows a 1-for-75 Reverse Stock Split effected on August 6, 2026, with shares last trading at $5.17 on August 20, 2026 before the deal priced at $6.50.

Jupiter Neurosciences, Inc. (NASDAQ: JUNS) is selling 307,692 shares of its common stock at $6.50 per share, a deal priced below the stock's most recent trading level. The offering, conducted through placement agent D. Boral Capital LLC, is structured as an issuer sale rather than a resale by existing holders. Shares were trading at $5.17 on August 20, 2026, ahead of the pricing.

Placement Agent Structure And Fees

D. Boral Capital is not committing to buy or resell any fixed number of shares. It has agreed only to use best efforts to place the full 307,692-share block with investors. Jupiter Neurosciences will pay D. Boral a cash fee equal to 7.0% of gross proceeds from the sale.

Dilution And Balance Sheet Snapshot

Investors buying into this offering at $6.50 per share face immediate dilution of $3.73 per share relative to that pro forma net tangible book value. The offering also follows a 1-for-75 reverse stock split effected on August 6, 2026, which reclassified every 75 pre-split shares into one share without altering Par Value or authorized share count.

Working Capital Is The Stated Purpose

Jupiter Neurosciences intends to direct net proceeds toward Working Capital and other general corporate purposes. The company's public float was measured at $12,163,998, based on 912,909 shares outstanding, of which 579,238 shares are held by non-affiliates, calculated using a Nasdaq closing price of $21.00 on June 26, 2026.

Outstanding Share Base And Overhangs

The post-offering share count is based on 912,909 shares outstanding as of August 20, 2026, a figure that excludes several categories of potential future dilution.

Source(s)

  • https://www.sec.gov/Archives/edgar/data/1679628/000149315226039784/form424b5.htm